These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1362958)

  • 21. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
    Lees GJ; Leong W
    Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMDA and non-NMDA receptor gene expression following global brain ischemia in rats: effect of NMDA and non-NMDA receptor antagonists.
    Pellegrini-Giampietro DE; Pulsinelli WA; Zukin RS
    J Neurochem; 1994 Mar; 62(3):1067-73. PubMed ID: 8113793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats.
    Engber TM; Anderson JJ; Boldry RC; Papa SM; Kuo S; Chase TN
    Neuroscience; 1994 Mar; 59(2):389-99. PubMed ID: 8008198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels.
    Nilsson P; Laursen H; Hillered L; Hansen AJ
    J Cereb Blood Flow Metab; 1996 Mar; 16(2):262-70. PubMed ID: 8594058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
    Gemignani A; Marchese S; Fontana G; Raiteri M
    Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended studies on the effect of glutamate antagonists on ischemic CA-1 damage.
    Diemer NH; Balchen T; Bruhn T; Christensen T; Vanicky I; Nielsen M; Johansen FF
    Acta Neurochir Suppl; 1996; 66():73-5. PubMed ID: 8780801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
    Kenny PJ; Gasparini F; Markou A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats.
    Iwasaki K; Chung EH; Egashira N; Hatip-Al-Khatib I; Mishima K; Egawa T; Irie K; Fujiwara M
    Brain Res; 2004 Jan; 995(1):131-9. PubMed ID: 14644478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
    von Euler M; Seiger A; Holmberg L; Sundström E
    Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.
    Sparapani M; Dall'Olio R; Gandolfi O; Ciani E; Contestabile A
    Exp Neurol; 1997 Nov; 148(1):157-66. PubMed ID: 9398458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro evaluation of AMPA receptor antagonists in rat hippocampal neurones and cultured mouse cortical neurones.
    Mathiesen C; Varming T; Jensen LH
    Eur J Pharmacol; 1998 Jul; 353(2-3):159-67. PubMed ID: 9726646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabotropic glutamate receptor agonist 1S,3R-ACPD stimulates and modulates NMDA receptor mediated excitotoxicity in organotypic hippocampal slice cultures.
    Blaabjerg M; Kristensen BW; Bonde C; Zimmer J
    Brain Res; 2001 Apr; 898(1):91-104. PubMed ID: 11292452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
    Arias RL; Tasse JR; Bowlby MR
    Brain Res; 1999 Jan; 816(2):299-308. PubMed ID: 9878799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analgesic effects of ionotropic glutamate receptor antagonists MK-801 and NBQX on collagen-induced arthritis rats].
    Zhu H; Zhu R; Deng ZD; Feng YC; Shen HL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):977-981. PubMed ID: 27987500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
    Li H; Buchan AM
    J Cereb Blood Flow Metab; 1993 Nov; 13(6):933-9. PubMed ID: 7691852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.